Optimum population-level use of artemisinin combination therapies: a modelling study.
Artemisinin combination therapies (ACTs) are used worldwide as first-line treatment against confirmed or suspected Plasmodium falciparum malaria. Despite the success of ACTs at reducing the global burden of malaria, emerging resistance to artemisinin threatens these gains. Countering onset of resist...
Päätekijät: | Nguyen, T, Olliaro, P, Dondorp, A, Baird, J, Lam, H, Farrar, J, Thwaites, G, White, N, Boni, M |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
Elsevier
2015
|
Samankaltaisia teoksia
-
Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
Tekijä: Nguyen, TD, et al.
Julkaistu: (2023) -
Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
Tekijä: van der Pluijm, RW, et al.
Julkaistu: (2022) -
Artemisinin combination therapy for vivax malaria.
Tekijä: Douglas, N, et al.
Julkaistu: (2010) -
Artemisinin-based combinations.
Tekijä: Ashley, E, et al.
Julkaistu: (2005) -
Triple artemisinin-based combination therapies for malaria – a new paradigm?
Tekijä: van der Pluijm, RW, et al.
Julkaistu: (2020)